It read, “Forget zombies and vampires, the scariest thing onscreen anywhere right now is Fed Up. Even Godzilla can’t rival ...

Obesity has become a major global problem. Since 1975, the number of overweight people around the world has almost tripled, ...

The study — published recently in the journal Social Science & Medicine — identified three key high school factors linked to ...

Hardworking Tennesseans have tried changes to diets and exercise to lose weight and maintain healthy lifestyles, but ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

New York lawmakers are pushing to strengthen laws banning false, predatory marketing and advertising for unhealthy foods to curb childhood obesity.

Gen Alpha (children 14 and younger) led the rise of GLP-1 utilization from 2023 to 2024, with an 85% growth rate in that period. But what is behind the sharp increase? 3 factors at play There are ...

Increased awareness and knowledge of GLP-1/GIP receptor agonists among women, with insights into public perspectives on ...

It’s all about GLP-1s on this week’s episode. For the Trends segment, we’re continuing the GLP-1 focus with an update on how Eli Lilly is overtaking Novo Nordisk in the diabetes and obesity treatment ...